LAUREN BARBER: Open Payments
NPI 1801353412 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,995 in 171 payments from 17 companies in 2025. Trend: 2023 $2,236 · 2024 $3,011 · 2025 $3,995
Food & beverage: $3,995
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $876 |
| Janssen Biotech, Inc. | 25 | $748 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $440 |
| Lilly USA, LLC | 12 | $327 |
| Ardelyx, Inc. | 15 | $292 |
| Celltrion USA Inc. | 9 | $192 |
| GENZYME CORPORATION | 7 | $188 |
| Aimmune Therapeutics, Inc. | 8 | $187 |
| Madrigal Pharmaceuticals | 11 | $150 |
| Regeneron Healthcare Solutions, Inc. | 5 | $141 |
Products named: TREMFYA, RINVOQ, ENTYVIO, DUPIXENT, OMVOH, IBSRELA, SKYRIZI, VEGZELMA.
Industry payments across KS — which companies pay providers there.
